IRVINE, Calif., Feb. 02, 2023 — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced that the company’s management team will participate at the SVB Securities Global Biopharma Conference. SVB Securities Global Biopharma ConferenceDate: Wednesday, Feb. 15,… Continue reading Reneo Pharmaceuticals to Participate in SVB Securities Global Biopharma Conference
